Skip to main content

Gate — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

1,203
Companies
$770.1M
Total invested
$8.3M
Avg. check
53
Industries
Biotechnology 8Medical 6Health Care 5Artificial Intelligence (AI) 4Pharmaceutical 4Biopharma 3+47 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 1,203
Numerion Labs
March 2026

Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Artificial Intelligence (AI) · San Francisco$19.8M Series D
VerbaFlo
March 2026

VerbaFlo is an AI-powered communications platform for real estate

Artificial Intelligence (AI) · Hertford$7.0M Seed
GlobalComix
March 2026

GlobalComix is a free digital reading and distribution platform that helps creators and publishers share and sell their comics.

Comics · New York$13.0M Series Unknown
CRISPR Therapeutics
March 2026

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Biopharma · Cambridge$550.0M Post-IPO Debt
MindImmune Therapeutics
March 2026

MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.

Biotechnology · Providence$5.0M Grant
Sats Terminal
March 2026

Sats Terminal the Bitcoin decentralized finance aggregation protocol.

Blockchain · DoverSeed
Plasmaleap
March 2026

Plasmaleap is a plasma technology company that manufactures and sells advanced zero-emissions chemical reactors for various sectors.

Industrial · Sydney$21.3M Series A
Stay22
February 2026

Stay22 is a travel tech leader helping publishers turn their audience’s travel intent into a new revenue stream

Events · Montréal$122.0M Private Equity
Axmed
February 2026

Axmed is a medical marketplace that offers access to medicines for healthcare providers through business and technology solutions.

Health Care · Basel$6.0M Grant
Tozaro
February 2026

Tozaro is a biotechnology company that develops synthetic affinity reagents for cell and gene therapy.

Biotechnology · Bedford$8.2M Venture - Series Unknown
Osmo
February 2026

Osmo gives computers a sense of smell that improves the health and wellbeing of human life.

Artificial Intelligence (AI) · New York$70.0M Series B
Plug
February 2026

Plug is a wholesale auction that facilitates online buying and selling of used EVs.

Automotive · Santa Monica$20.0M Series A
Heritable Agriculture
January 2026

Heritable Agriculture focuses on improving plant breeding and biotechnology to strengthen the world's food and agricultural systems.

Agriculture · Mountain View$5.0M Grant
Game Actor
January 2026

Game Actor is a social media platform where gamers can show statistics, connect with others, and share gaming experiences

Gamification · Sariyer$400K Seed
Cork Protocol
January 2026

Cork offers collateralized swaps against any pegged asset.

Decentralized Finance (DeFi) · New York$5.5M Seed
Zelira Hope 1
January 2026

Zelira Hope 1 is owned by Zelira Therapeutics, that focuses on advancing the company's lead cannabinoid-based drug candidate.

Perth$33.0M Series A
Eyam Health
January 2026

Eyam Health concentrates on the investigation and creation of vaccines for defending against infectious diseases.

Biopharma · Surrey$327K Grant
SkyFi®
January 2026

SkyFi® is an earth intelligence platform that provides satellite imagery and analytics to help interpret and analyze planetary data.

Aerospace · Austin$12.7M Series A
Wedge
January 2026

Competitive Wedge offers a one-way recorded video interview built for the demands of modern recruiting.

Human Resources · Grand Rapids$1.5M Venture - Series Unknown
Just - Evotec Biologics
January 2026

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Biopharma · SeattleGrant
vitrealab
January 2026

vitrealab unlocks Augmented Reality for everyday use, with its proprietary laser matrix photonic integrated circuit.

Vienna$11.0M Series A
STRM.BIO
January 2026

STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.

Biotechnology · Cambridge$8.0M Seed
Bactolife
January 2026

Bactolife is a biotechnology company that develops biological solutions to support gut health.

Biotechnology · Lyngby$35.2M Series B
Globavend
December 2025

Globavend e-commerce logistic company that offers end-to-end solution via air freight and on-carriage parcel transportation and delivery.

Freight Service · Perth$934K Post-IPO Equity

Where Gate invests

Biotechnology8
Medical6
Health Care5
Artificial Intelligence (AI)4
Pharmaceutical4
Biopharma3

About Gate's portfolio

How many companies has Gate invested in?▸

Gate has invested in 1,203 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Gate invest in?▸

Gate's top investment sectors include Biotechnology, Medical, Health Care, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 53 different industry categories.

What is Gate's largest investment?▸

Among tracked funding rounds, CRISPR Therapeutics received $550.0M in a Post-IPO Debt round. Gate's total known invested capital is $770.1M.

What is the average investment size for Gate?▸

Gate's average investment size is $8.3M across its portfolio of 1,203 companies.

What are Gate's most recent investments?▸

Recent Gate portfolio additions include Numerion Labs, VerbaFlo, GlobalComix, CRISPR Therapeutics, MindImmune Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 1,203 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →